Noven Pharmaceuticals To Present At Lehman Brothers Healthcare Conference

-- Noven Pharmaceuticals, Inc. (Nasdaq: NOVN) today announced that Robert Strauss, its President, CEO & Chairman, will present Noven's business and prospects on Friday, March 5 at 11:15 a.m. Eastern Standard Time at the Lehman Brothers Annual Global Healthcare Conference. A live webcast of the presentation will be accessible to the public at www.noven.com and at www.lehman.com/conferences/200403Healthcare, and a rebroadcast will be available thereafter at www.noven.com.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven’s prescription patches are sold in over 30 countries, and a range of new patches are being developed in collaboration with Novartis Pharma AG, Shire Pharmaceuticals Group plc, P&G Pharmaceuticals, Endo Pharmaceuticals Inc. and others. With the most advanced and broadly applicable transdermal technology in its class, Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See www.noven.com for additional information.

Contact:
Investor & Media Contact

Joseph C. Jones
Vice President – Corporate Affairs
Noven Pharmaceuticals, Inc.
305-253-1916